{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T01:48:26Z","timestamp":1784166506048,"version":"3.55.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T00:00:00Z","timestamp":1525219200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s00774-018-0922-3","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T10:42:49Z","timestamp":1525257769000},"page":"336-341","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["The characteristics of clinical changes in primary hyperparathyroidism in Chinese patients"],"prefix":"10.1007","volume":"37","author":[{"given":"Xiao-Ai","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-Jun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,2]]},"reference":[{"key":"922_CR1","first-page":"49","volume":"1","author":"AACE\/AAES Task Force on Primary Hyperparathyroidism","year":"2005","unstructured":"AACE\/AAES Task Force on Primary Hyperparathyroidism (2005) The American Association of Clinical Endocrinologists and the American Association of Endocrine Surgeons position statement on the diagnosis and management of primary hyperparathyroidism. Endocr Pract 1:49\u2013154","journal-title":"Endocr Pract"},{"key":"922_CR2","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1056\/NEJMcp032200","volume":"350","author":"JP Bilezikian","year":"2004","unstructured":"Bilezikian JP, Silverberg SJ (2004) Clinical practice. Asymptomatic primary hyperparathyroidism. N Engl J Med 350:1746\u20131751","journal-title":"N Engl J Med"},{"key":"922_CR3","first-page":"5","volume":"F1000 Faculty R","author":"L Bandeira","year":"2016","unstructured":"Bandeira L, Bilezikian J (2016) Primary hyperparathyroidism. F1000Res F1000 Faculty Rev:5","journal-title":"F1000Res"},{"key":"922_CR4","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1590\/S0004-27302013000600002","volume":"57","author":"F Bandeira","year":"2013","unstructured":"Bandeira F, Griz L, Chaves N, Carvalho NC, Borges LM, Lazaretti-Castro M, Borba V, Castro LC, Borges JL, Bilezikian J (2013) Diagnosis and management of primary hyperparathyroidism\u2014a scientific statement from the Department of Bone Metabolism, the Brazilian Society for Endocrinology and Metabolism. Arq Braz Endocrinol Metabol 57:406\u2013424","journal-title":"Arq Braz Endocrinol Metabol"},{"key":"922_CR5","doi-asserted-by":"publisher","first-page":"921814","DOI":"10.1155\/2011\/921814","volume":"2011","author":"PV Pradeep","year":"2011","unstructured":"Pradeep PV, Jayashree B, Mishra A, Mishra SK (2011) Systematic review of primary hyperparathyroidism in India: the past, present, and the future trends. Int J Endocrinol 2011:921814","journal-title":"Int J Endocrinol"},{"key":"922_CR6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.4103\/0022-3859.65279","volume":"56","author":"RA Gopal","year":"2010","unstructured":"Gopal RA, Acharya SV, Bandgar T, Menon PS, Dalvi AN, Shah NS (2010) Clinical profile of primary hyperparathyroidism from western India: a single center experience. J Postgrad Med 56:79\u201384","journal-title":"J Postgrad Med"},{"key":"922_CR7","first-page":"CR86","volume":"12","author":"S Hamidi","year":"2006","unstructured":"Hamidi S, Soltani A, Hedayat A, Kamalian N (2006) Primary hyperparathyroidism: a review of 177 cases. Med Sci Monit 12:CR86\u2013CR89","journal-title":"Med Sci Monit"},{"key":"922_CR8","first-page":"394","volume":"62","author":"UH Malabu","year":"2007","unstructured":"Malabu UH, Founda MA (2007) Primary hyperparathyroidism in Saudi Arabia: a review of 46 cases. Med J Malays 62:394\u2013397","journal-title":"Med J Malays"},{"key":"922_CR9","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1210\/jc.2012-2914","volume":"98","author":"L Zhao","year":"2013","unstructured":"Zhao L, Liu JM, He XY, Zhao HY, Sun LH, Tao B, Zhang MJ, Chen X, Wang WQ, Ning G (2013) The changing clinical patterns of primary hyperparathyroidism in Chinese patients: data from 2000 to 2010 in a single clinical center. J Clin Endocrinol Metab 98:721\u2013728","journal-title":"J Clin Endocrinol Metab"},{"key":"922_CR10","first-page":"651","volume":"46","author":"ST Yan","year":"2007","unstructured":"Yan ST, Tian H, Li CL, Zong WY, Shao YH, Zhong WW, Gong YP (2007) A preliminary survey of primary hyperparathyroidism in middle-aged and elderly Beijing Chinese. Zhonghua Nei Ke Za Zhi 46:651\u2013653","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"922_CR11","first-page":"483","volume":"5","author":"X Xiaoping","year":"2006","unstructured":"Xiaoping X, Ou W, Xunwu M, Weibo X, Mei L, Yan J, Guiyan H, Yingying H, Huaicheng L (2006) Comparison of clinical manifestations in patients with primary hyperparathyroidism between districts of Beijing and New York. Diagn Theory Pract 5:483\u2013486","journal-title":"Diagn Theory Pract"},{"key":"922_CR12","first-page":"330","volume":"33","author":"D Jianyu","year":"2011","unstructured":"Jianyu D, Xian G, Yu Z (2011) Clinical symptoms in 455 hyperparathyroidism patients. Acta Acad Med Sin 33:330\u2013333","journal-title":"Acta Acad Med Sin"},{"key":"922_CR13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/cen.13055","volume":"85","author":"S Xue","year":"2016","unstructured":"Xue S, Chen H, Lv C, Shen X, Ding J, Liu J, Chen X (2016) Preoperative diagnosis and prognosis in 40 parathyroid carcinoma patients. Clin Endocrinol (Oxf) 85:29\u201336","journal-title":"Clin Endocrinol (Oxf)"},{"key":"922_CR14","first-page":"4322","volume":"3","author":"B Sun","year":"2017","unstructured":"Sun B, Guo B, Wu B, Kang J, Deng X, Zhang Z, Fan Y (2017) Characteristics, management, and outcome of primary hyperparathyroidism at a single clinical centre from 2005 to 2016. Osteoporos Int 3:4322\u20134327","journal-title":"Osteoporos Int"},{"key":"922_CR15","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jocd.2012.11.005","volume":"16","author":"SJ Silverberg","year":"2013","unstructured":"Silverberg SJ, Walker MD, Bilezikian JP (2013) Asymptomatic primary hyperparathyroidism. J Clin Densitom 16:14\u201321","journal-title":"J Clin Densitom"},{"key":"922_CR16","first-page":"80","volume":"31","author":"K Duan","year":"2015","unstructured":"Duan K, Mete \u00d6 (2015) Parathyroid carcinoma: diagnosis and clinical implications. Turk Patoloji Derg 31:80\u201397","journal-title":"Turk Patoloji Derg"},{"key":"922_CR17","first-page":"187","volume":"7","author":"Chinese Society of Bone and Mineral Research, Metabolic osteopathy group, endocrine division, Chinese Medical Association","year":"2014","unstructured":"Chinese Society of Bone and Mineral Research, Metabolic osteopathy group, endocrine division, Chinese Medical Association (2014) Guidelines for the diagnosis and treatment of primary hyperparathyroidism. Chin J Osteoporos Bone Miner Res 7:187\u2013198","journal-title":"Chin J Osteoporos Bone Miner Res"},{"key":"922_CR18","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1053\/j.semdp.2013.06.003","volume":"30","author":"ZW Baloch","year":"2013","unstructured":"Baloch ZW, LiVolsi VA (2013) Pathology of the parathyroid glands in hyperparathyroidism. Semin Diagn Pathol 30:165\u2013177","journal-title":"Semin Diagn Pathol"},{"key":"922_CR19","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.path.2014.08.004","volume":"7","author":"VA LiVolsi","year":"2014","unstructured":"LiVolsi VA, Montone KT, Baloch ZN (2014) Parathyroid: the pathology of hyperparathyroidism. Surg Pathol Clin 7:515\u2013531","journal-title":"Surg Pathol Clin"},{"key":"922_CR20","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.5858\/2008-132-1251-PHACP","volume":"132","author":"RA DeLellis","year":"2008","unstructured":"DeLellis RA, Mazzaglia P, Mangray S (2008) Primary hyperparathyroidism: a current perspective. Arch Pathol Lab Med 132:1251\u20131262","journal-title":"Arch Pathol Lab Med"},{"key":"922_CR21","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ando.2015.03.003","volume":"76","author":"D Betea","year":"2015","unstructured":"Betea D, Potorac I, Beckers A (2015) Parathyroid carcinoma: challenges in diagnosis and treatment. Ann Endocrinol (Paris) 76:169\u2013177","journal-title":"Ann Endocrinol (Paris)"},{"key":"922_CR22","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s10354-013-0235-z","volume":"163","author":"RW Gasser","year":"2013","unstructured":"Gasser RW (2013) Clinical aspects of primary hyperparathyroidism: clinical manifestations, diagnosis, and therapy. Wien Med Wochenschr 163:397\u2013402","journal-title":"Wien Med Wochenschr"},{"key":"922_CR23","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1590\/S0100-879X2007000400010","volume":"40","author":"UE Oliveira","year":"2007","unstructured":"Oliveira UE, Ohe MN, Santos RO, Cervantes O, Abrah\u00e3o M, Lazaretti-Castro M, Vieira JG, Hauache OM (2007) Analysis of the diagnostic presentation profile, parathyroidectomy indication and bone mineral density follow-up of Brazilian patients with primary hyperparathyroidism. Braz J Med Biol Res 40:519\u2013526","journal-title":"Braz J Med Biol Res"},{"key":"922_CR24","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ando.2015.03.001","volume":"76","author":"DP Macfarlane","year":"2015","unstructured":"Macfarlane DP, Yu N, Leese GP (2015) Asymptomatic and mild primary hyperparathyroidism. Ann Endocrinol (Paris) 76:120\u2013127","journal-title":"Ann Endocrinol (Paris)"},{"key":"922_CR25","first-page":"N18","volume":"17","author":"S Adami","year":"2002","unstructured":"Adami S, Marcocci C, Gatti D (2002) Epidemiology of primary hyperparathyroidism in Europe. J Bone Miner Res 17:N18\u2013N23","journal-title":"J Bone Miner Res"},{"key":"922_CR26","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/dmrr.199","volume":"17","author":"WH Taylor","year":"2001","unstructured":"Taylor WH, Khaleeli AA (2001) Coincident diabetes mellitus and primary hyperparathyroidism. Diabetes Metab Res Rev 17:175\u2013180","journal-title":"Diabetes Metab Res Rev"},{"key":"922_CR27","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1111\/j.1464-5491.2009.02804.x","volume":"26","author":"F Tassone","year":"2009","unstructured":"Tassone F, Procopio M, Gianotti L, Visconti G, Pia A, Terzolo M, Borretta G (2009) Insulin resistance is not coupled with defective insulin secretion in primary hyperparathyroidism. Diabet Med 26:968\u2013973","journal-title":"Diabet Med"},{"key":"922_CR28","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1136\/jcp.47.11.982","volume":"47","author":"WS Smellie","year":"1994","unstructured":"Smellie WS, O\u2019Donnell J, Davidson H, Couper J, Logue FC (1994) Effects of changes in acid and calcium concentration on fasting serum insulin, proinsulin, and glucose concentrations. J Clin Pathol 47:982\u2013985","journal-title":"J Clin Pathol"},{"key":"922_CR29","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/j.1365-2265.2005.02371.x","volume":"63","author":"B Moosgaard","year":"2005","unstructured":"Moosgaard B, Vestergaard P, Heickendorff L, Melsen F, Christiansen P, Mosekilde L (2005) Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism. Clin Endocrinol (Oxf) 63:506\u2013513","journal-title":"Clin Endocrinol (Oxf)"},{"key":"922_CR30","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/BF03344140","volume":"29","author":"P Boudou","year":"2006","unstructured":"Boudou P, Ibrahim F, Cormier C, Sarfati E, Souberbielle JC (2006) A very high incidence of low 25 hydroxy-vitamin D serum concentration in a French population of patients with primary hyperparathyroidism. J Endocrinol Invest 29:511\u2013515","journal-title":"J Endocrinol Invest"},{"key":"922_CR31","doi-asserted-by":"publisher","first-page":"E313","DOI":"10.3390\/nu9030313","volume":"9","author":"RE Man","year":"2017","unstructured":"Man RE, Li LJ, Cheng CY, Wong TY, Lamoureux E, Sabanayagam C (2017) Prevalence and determinants of suboptimal vitamin D levels in a multiethnic Asian population. Nutrients 9:E313","journal-title":"Nutrients"},{"key":"922_CR32","doi-asserted-by":"publisher","first-page":"V100","DOI":"10.1359\/jbmr.07s202","volume":"22","author":"SJ Silverberg","year":"2007","unstructured":"Silverberg SJ (2007) Vitamin D deficiency and primary hyperparathyroidism. J Bone Miner Res 22:V100\u2013V104","journal-title":"J Bone Miner Res"},{"key":"922_CR33","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jocd.2012.11.008","volume":"16","author":"MD Walker","year":"2013","unstructured":"Walker MD, Rubin M, Silverberg SJ (2013) Nontraditional manifestations of primary hyperparathyroidism. J Clin Densitom 16:40\u201347","journal-title":"J Clin Densitom"},{"key":"922_CR34","doi-asserted-by":"publisher","first-page":"3580","DOI":"10.1210\/jc.2014-1415","volume":"99","author":"SJ Silverberg","year":"2014","unstructured":"Silverberg SJ, Clarke BL, Peacock M, Bandeira F, Boutroy S, Cusano NE, Dempster D, Lewiecki EM, Liu JM, Minisola S, Rejnmark L, Silva BC, Walker MD, Bilezikian JP (2014) Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the fourth international workshop. J Clin Endocrinol Metabol 99:3580\u20133594","journal-title":"J Clin Endocrinol Metabol"},{"key":"922_CR35","first-page":"2791","volume":"26","author":"S Jian","year":"2010","unstructured":"Jian S, Yuan Y, Xinpo X, Ming S (2010) Diagnosis and analysis of 73 cases primary hyperthyroidism. J Pract Med 26:2791\u20132793","journal-title":"J Pract Med"},{"key":"922_CR36","first-page":"1798","volume":"26","author":"W Ou","year":"2006","unstructured":"Ou W, Xiaoping X, Xunwu M, Weibo X, Mei L, Yu Z, Heng G, Tonghua L, Guiyan, H, Yingying H, Huaicheng L (2006) Comparison of clinical characteristics in primary hyperparathyroidism among different pathologic types. Chin J Pract Intern Med 26:1798\u20131801","journal-title":"Chin J Pract Intern Med"},{"key":"922_CR37","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1590\/0004-2730000003381","volume":"58","author":"F Bandeira","year":"2014","unstructured":"Bandeira F, Cusano NE, Silva BC, Cassibba S, Almeida CB, Machado VC (2014) Bone disease in primary hyperparathyroidism. Arq Braz Endocrinol Metabol 58:553\u2013561","journal-title":"Arq Braz Endocrinol Metabol"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-018-0922-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00774-018-0922-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-018-0922-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,21]],"date-time":"2022-08-21T15:05:19Z","timestamp":1661094319000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00774-018-0922-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,2]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["922"],"URL":"https:\/\/doi.org\/10.1007\/s00774-018-0922-3","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,2]]},"assertion":[{"value":"4 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}